{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:27:20Z","timestamp":1787225240444,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2021YFC2500200"],"award-info":[{"award-number":["2021YFC2500200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2021YFC2500204"],"award-info":[{"award-number":["2021YFC2500204"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Technologies R&D Program of Guangdong Province","award":["2023B1111030004"],"award-info":[{"award-number":["2023B1111030004"]}]},{"name":"Guangdong Provincial Clinical Research","award":["2020B11170013"],"award-info":[{"award-number":["2020B11170013"]}]},{"DOI":"10.13039\/501100012176","name":"Program of Introducing Talents of Discipline to Universities","doi-asserted-by":"crossref","award":["D18005"],"award-info":[{"award-number":["D18005"]}],"id":[{"id":"10.13039\/501100012176","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82030022"],"award-info":[{"award-number":["82030022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82330020"],"award-info":[{"award-number":["82330020"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2024A1515220155"],"award-info":[{"award-number":["2024A1515220155"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["JASN"],"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>The incidence rate of cardiovascular death in the overall GN cohort varied by primary cause.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Compared with the general population, patients with various subtypes of GN exhibited higher cardiovascular death risks.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Early detection and accurate assessment of cardiovascular involvement in the GN population with different etiologies were essential.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>It was well-established that patients with GN face an elevated cardiovascular risk, yet little was known about the differential impacts of various etiologies of glomerular disease on cardiovascular outcomes. In this large cohort study encompassing patients with distinct forms of GN, we aimed to compare the effects of different etiologies on cardiovascular death events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using data from the China Renal Data System database, we identified 66,247 patients with GN across 14 distinct etiologies between 2000 and 2022. The risks of cardiovascular death, ischemic heart disease\u2013associated death, and stroke-associated death among different types of patients were compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Within a cohort of 66,247 patients with GN, IgA nephropathy (39%) was the most prevalent etiology, followed by lupus nephritis (17%) and membranous nephropathy (16%). During follow-up, 971 cardiovascular deaths (1%), 337 ischemic heart\u2013associated deaths (0.5%), and 286 stroke-associated deaths (0.4%) were recorded. The overall crude cardiovascular death rates across GN subtypes ranged from 0.7 to 22.6 per 1000 person-years. All patients with glomerular diseases demonstrated elevated cardiovascular death risks compared with the general population, with lupus nephritis exhibiting the highest risk (indirect standardized mortality ratio of 27.9) and minimal change disease the lowest (indirect standardized mortality ratio of 3.91). Furthermore, when compared directly with patients with minimal change disease, all other GN subtypes were associated with significantly greater cardiovascular death risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with different underlying glomerular diseases exhibited markedly heterogeneous and elevated cardiovascular risk profiles.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1681\/asn.0000001165","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T22:00:07Z","timestamp":1784757607000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Cardiovascular Risk across Different Glomerular Diseases"],"prefix":"10.1681","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9504-8394","authenticated-orcid":false,"given":"Luhua","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caoxiang","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7399-3857","authenticated-orcid":false,"given":"Yuqi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1392-6822","authenticated-orcid":false,"given":"Yinfang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1130-6755","authenticated-orcid":false,"given":"Lantian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5372-5552","authenticated-orcid":false,"given":"Fan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8267-7909","authenticated-orcid":false,"given":"Sheng","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"10518","key":"B1-20260820","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(25)01853-7","article-title":"Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the global burden of disease study 2023","volume":"406","author":"Mark","year":"2025","journal-title":"Lancet."},{"issue":"11","key":"B2-20260820","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41581-022-00616-6","article-title":"Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease","volume":"18","author":"Matsushita","year":"2022","journal-title":"Nat Rev Nephrol."},{"issue":"23","key":"B3-20260820","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1093\/eurheartj\/ehaf167","article-title":"Cardiovascular disease in chronic kidney disease","volume":"46","author":"Marx-Sch\u00fctt","year":"2025","journal-title":"Eur Heart J."},{"key":"B4-20260820","doi-asserted-by":"crossref","first-page":"1501175","DOI":"10.3389\/fmed.2024.1501175","article-title":"Global, regional, and national burden inequality of chronic kidney disease, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"11","author":"Guo","year":"2025","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"B5-20260820","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2215\/CJN.0000000000000017","article-title":"Global, regional, and National burden of CKD due to glomerulonephritis from 1990 to 2019: a systematic analysis from the global burden of disease study 2019","volume":"18","author":"Hu","year":"2023","journal-title":"Clin J Am Soc Nephrol."},{"issue":"7","key":"B6-20260820","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","article-title":"Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data","volume":"3","author":"Matsushita","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"11","key":"B7-20260820","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.3899\/jrheum.110329","article-title":"High risk of ischemic heart disease in patients with lupus nephritis","volume":"38","author":"Faurschou","year":"2011","journal-title":"J Rheumatol."},{"issue":"5","key":"B8-20260820","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.kint.2015.12.041","article-title":"Patients with primary membranous nephropathy are at high risk of cardiovascular events","volume":"89","author":"Lee","year":"2016","journal-title":"Kidney Int."},{"issue":"7","key":"B9-20260820","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1093\/ndt\/gfl062","article-title":"Vascular diseases and their risk factors in IgA nephropathy","volume":"21","author":"Myllym\u00e4ki","year":"2006","journal-title":"Nephrol Dial Transplant."},{"issue":"11","key":"B10-20260820","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/eurheartj\/ehy422","article-title":"Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis","volume":"40","author":"O'Shaughnessy","year":"2019","journal-title":"Eur Heart J."},{"issue":"6","key":"B11-20260820","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1053\/j.ajkd.2022.04.005","article-title":"The risk of cardiovascular events in individuals with primary glomerular diseases","volume":"80","author":"Canney","year":"2022","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"B12-20260820","doi-asserted-by":"crossref","first-page":"19119","DOI":"10.1038\/s41598-023-46268-9","article-title":"Years of life lost and long-term outcomes due to glomerular disease in a Southeast Asian cohort","volume":"13","author":"Janphram","year":"2023","journal-title":"Sci Rep."},{"issue":"1","key":"B13-20260820","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2471\/BLT.15.153148","article-title":"An integrated national mortality surveillance system for death registration and mortality surveillance, China","volume":"94","author":"Liu","year":"2016","journal-title":"Bull World Health Organ."},{"issue":"1","key":"B14-20260820","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1038\/s41467-023-39474-6","article-title":"Predicting in-hospital outcomes of patients with acute kidney injury","volume":"14","author":"Wu","year":"2023","journal-title":"Nat Commun."},{"issue":"7","key":"B15-20260820","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1681\/ASN.0000000000000125","article-title":"Detecting neonatal AKI by serum cystatin C","volume":"34","author":"Xu","year":"2023","journal-title":"J Am Soc Nephrol."},{"issue":"12","key":"B16-20260820","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.7326\/M24-0178","article-title":"Comparative effectiveness and safety of atorvastatin versus rosuvastatin: a multi-database cohort study","volume":"177","author":"Zhou","year":"2024","journal-title":"Ann Intern Med."},{"issue":"12","key":"B17-20260820","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1681\/ASN.0000000775","article-title":"Discontinuation of renin-angiotensin system inhibitors during acute kidney injury episode and all-cause mortality: target trial emulation studies","volume":"36","author":"Nie","year":"2025","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"B18-20260820","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis."},{"issue":"9","key":"B19-20260820","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med."},{"issue":"1","key":"B20-20260820","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1681\/ASN.2007020156","article-title":"Regional implementation of creatinine measurement standardization","volume":"19","author":"Komenda","year":"2008","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B21-20260820","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12916-020-01632-8","article-title":"Measuring the completeness of death registration in 2844 Chinese counties in 2018","volume":"18","author":"Zeng","year":"2020","journal-title":"BMC Med."},{"key":"B23-20260820","first-page":"1","article-title":"Statistical methods in cancer research. volume II--the design and analysis of cohort studies","volume":"82","author":"Breslow","year":"1987","journal-title":"IARC Sci Publ."},{"issue":"6","key":"B24-20260820","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American heart association's PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation."},{"issue":"10","key":"B25-20260820","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/sim.4154","article-title":"On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data","volume":"30","author":"Uno","year":"2011","journal-title":"Stat Med."},{"issue":"1","key":"B26-20260820","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/sim.4026","article-title":"Several methods to assess improvement in risk prediction models: extension to survival analysis","volume":"30","author":"Chambless","year":"2011","journal-title":"Stat Med."},{"issue":"3","key":"B27-20260820","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/sim.1946","article-title":"Explained randomness in proportional hazards models","volume":"24","author":"O'Quigley","year":"2005","journal-title":"Stat Med."},{"issue":"1","key":"B28-20260820","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/joim.20024","article-title":"Primary glomerular diseases and long-term adverse health outcomes: a nationwide cohort study","volume":"297","author":"Faucon","year":"2025","journal-title":"J Intern Med."},{"issue":"3","key":"B29-20260820","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s40265-022-01830-z","article-title":"Diagnosis and treatment of AL amyloidosis","volume":"83","author":"Palladini","year":"2023","journal-title":"Drugs."},{"issue":"4","key":"B30-20260820","doi-asserted-by":"crossref","first-page":"103531","DOI":"10.1016\/j.autrev.2024.103531","article-title":"Epidemiology, clinical features, risk factors, and outcomes in anti-glomerular basement membrane disease: a systematic review and meta-analysis","volume":"23","author":"Kuang","year":"2024","journal-title":"Autoimmun Rev."},{"issue":"5","key":"B31-20260820","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.kint.2022.07.026","article-title":"Arterial stiffness, endothelial dysfunction and impaired fibrinolysis are pathogenic mechanisms contributing to cardiovascular risk in ANCA-associated vasculitis","volume":"102","author":"Farrah","year":"2022","journal-title":"Kidney Int."},{"issue":"12","key":"B32-20260820","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1093\/ndt\/gfaf070","article-title":"Cardiovascular involvement in ANCA-associated vasculitis","volume":"40","author":"Sarmad","year":"2025","journal-title":"Nephrol Dial Transplant."},{"key":"B33-20260820","doi-asserted-by":"crossref","first-page":"107466","DOI":"10.1016\/j.intimp.2021.107466","article-title":"Patients with systemic lupus erythematosus face a high risk of cardiovascular disease: a systematic review and meta-analysis","volume":"94","author":"Lu","year":"2021","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"B34-20260820","doi-asserted-by":"crossref","first-page":"e001152","DOI":"10.1136\/lupus-2024-001152","article-title":"Cardiovascular risk factors and complications in patients with systemic lupus erythematosus with and without nephritis: a systematic review and meta-analysis","volume":"11","author":"Wong","year":"2024","journal-title":"Lupus Sci Med."},{"issue":"2","key":"B35-20260820","doi-asserted-by":"crossref","first-page":"e13441","DOI":"10.1111\/eci.13441","article-title":"Endothelial dysfunction and cardiovascular risk in lupus nephritis: new roles for old players?","volume":"51","author":"Mancardi","year":"2021","journal-title":"Eur J Clin Invest."},{"issue":"1","key":"B36-20260820","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev-pathol-051220-092001","article-title":"Pathogenesis of focal segmental glomerulosclerosis and related disorders","volume":"20","author":"Altintas","year":"2025","journal-title":"Annu Rev Pathol."},{"issue":"1","key":"B37-20260820","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41572-023-00476-9","article-title":"IgA nephropathy","volume":"9","author":"Stamellou","year":"2023","journal-title":"Nat Rev Dis Primers."}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000001165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:00:16Z","timestamp":1787223616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000001165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":36,"URL":"https:\/\/doi.org\/10.1681\/asn.0000001165","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"2025-12-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}